SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-23-001278
Filing Date
2023-01-19
Accepted
2023-01-19 16:58:55
Documents
2
Period of Report
2023-01-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_167416551697789.html 4  
1 FORM 4 wf-form4_167416551697789.xml 4 3263
2 LOOKER POA ex24looker.txt EX-24 3925
  Complete submission text file 0001628280-23-001278.txt   8669
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Issuer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TRILLIUM THERAPEUTICS INC. 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9
Business Address
Looker Benjamin (Reporting) CIK: 0001859509 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35986 | Film No.: 23538017